Found: 6
Select item for more details and to access through your institution.
A siRNA targets and inhibits a broad range of SARS‐CoV‐2 infections including Delta variant.
- Published in:
- EMBO Molecular Medicine, 2022, v. 14, n. 4, p. 1, doi. 10.15252/emmm.202115298
- By:
- Publication type:
- Article
Tag-Free SARS-CoV-2 Receptor Binding Domain (RBD), but Not C-Terminal Tagged SARS-CoV-2 RBD, Induces a Rapid and Potent Neutralizing Antibody Response.
- Published in:
- Vaccines, 2022, v. 10, n. 11, p. 1839, doi. 10.3390/vaccines10111839
- By:
- Publication type:
- Article
A Longitudinal Nine-Year Study of the Molecular Epidemiology of Carbapenemase-Producing Enterobacterales Isolated From a Regional Hospital in Taiwan: Predominance of Carbapenemase KPC-2 and OXA-48.
- Published in:
- Frontiers in Microbiology, 2022, v. 13, p. 1, doi. 10.3389/fmicb.2022.703113
- By:
- Publication type:
- Article
Combination of modified carbapenem inactivation method (mCIM) and EDTA-CIM (eCIM) for phenotypic detection of carbapenemase-producing Enterobacteriaceae.
- Published in:
- BMC Microbiology, 2020, v. 20, n. 1, p. N.PAG, doi. 10.1186/s12866-020-02010-3
- By:
- Publication type:
- Article
IFN‐stimulated metabolite transporter ENT3 facilitates viral genome release.
- Published in:
- EMBO Reports, 2023, v. 24, n. 3, p. 1, doi. 10.15252/embr.202255286
- By:
- Publication type:
- Article
Elicitation of potent neutralizing antibodies in obese mice by ISA 51-adjuvanted SARS-CoV-2 spike RBD-Fc vaccine.
- Published in:
- Applied Microbiology & Biotechnology, 2023, v. 107, n. 9, p. 2983, doi. 10.1007/s00253-023-12490-8
- By:
- Publication type:
- Article